Log in to save to my catalogue

"Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets...

"Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2195238030

"Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches

About this item

Full title

"Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches

Publisher

England: Taylor & Francis

Journal title

Drug delivery, 2017-01, Vol.24 (1), p.608-621

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

More than 35 million people are living with HIV worldwide with approximately 2.3 million new infections per year. Cascade of events (cell entry, virus replication, assembly and release of newly formed virions) is involved in the HIV-1 transmission process. Every single step offers a potential therapeutic strategy to halt this progression and HIV fu...

Alternative Titles

Full title

"Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2195238030

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2195238030

Other Identifiers

ISSN

1071-7544

E-ISSN

1521-0464

DOI

10.1080/10717544.2016.1228717

How to access this item